Stock Price
2,046.00
Daily Change
-10.00 -0.49%
Monthly
7.40%
Yearly
62.90%
Q2 Forecast
2,011.63

EPS Reference Time Actual Consensus Previous
2026-05-21 FY2026H2 AM 0.01 0.92
2025-11-20 FY2026H1 AM 0.51 0.00 0.57
2025-05-22 FY2025H2 AM 0.92 0.01 82.2
2024-11-27 FY2025H1 0.57 0.75 0.591
2024-05-23 FY2024H2 82.20 0.94 0.9



Peers Price Chg Day Year Date
Covestro 59.60 -0.20 -0.33% 1.02% Apr/24
Air Liquide 188.36 0.50 0.27% 5.70% Apr/25
Arkema 61.70 0 0% -6.52% Apr/24
Akzo Nobel 52.30 -0.52 -0.98% -7.17% Apr/24
BASF 54.32 0.08 0.15% 19.44% Apr/25
Bayer 38.50 -1.54 -3.85% 67.54% Apr/25
Croda International 2,913.00 -60.00 -2.02% -1.92% Apr/24
Givaudan 2,814.00 -7.00 -0.25% -27.38% Apr/24
Johnson Matthey 2,046.00 -10.00 -0.49% 62.90% Apr/24
Linde 433.60 5.00 1.17% 10.73% Apr/24

Indexes Price Day Year Date
EU600 611 -3.55 -0.58% 17.33% Apr/24

Johnson Matthey traded at 2,046.00 this Friday April 24th, decreasing 10.00 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, Johnson Matthey lost 7.40 percent. Over the last 12 months, its price rose by 62.90 percent. Looking ahead, we forecast Johnson Matthey to be priced at 2,011.63 by the end of this quarter and at 1,911.93 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson Matthey Plc is a provider of catalysts and catalyst systems to reduce emissions from vehicles and industry. The Company serves customers in global automotive, chemicals, pharmaceuticals and other industrial markets. The Company delivers its solutions through four global sectors: clean air, efficient natural resources, health and new markets. The clean air segment provides catalysts and technologies that abate emissions. The efficient natural resources segment offers products and processes that conserve and recycle scarce resources using less energy and fewer raw materials to chemicals, energy, transport and healthcare sectors. Health segment provides capabilities in complex chemistry, manufacturing and scale up to create active pharmaceutical ingredients and other solutions for niche areas. Its new market segment is engaged in applying its science into emerging opportunities, such as battery materials and fuel cells in the healthcare, transport, energy and chemicals segment.